Values First Advisors, Inc. Exact Sciences Corp Transaction History

Values First Advisors, Inc.

$182 Million
Q3 2024

A detailed history of Values First Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Values First Advisors, Inc. holds 9,558 shares of EXAS stock, worth $505,713. This represents 0.36% of its overall portfolio holdings.

Number of Shares

9,558

Previous 7,701 24.11%

Holding current value

$505,713

Previous $325,000 100.0%

% of portfolio

0.36%

Previous 0.2%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$42.43 - $70.83 $78,792 - $131,531	1,857 Added 24.11%	9,558 $650,000
Q2 2024 Jul 19, 2024	BUY	$41.33 - $74.26 $29,716 - $53,392	719 Added 10.3%	7,701 $325,000
Q1 2024 Apr 23, 2024	SELL	$56.27 - $73.77 $337,113 - $441,956	-5,991 Reduced 46.18%	6,982 $482,000
Q4 2023 Jan 18, 2024	BUY	$59.06 - $75.72 $137,550 - $176,351	2,329 Added 21.88%	12,973 $959,000
Q3 2023 Nov 08, 2023	BUY	$65.94 - $99.04 $37,783 - $56,749	573 Added 5.69%	10,644 $726,000
Q2 2023 Aug 02, 2023	BUY	$62.68 - $95.05 $34,662 - $52,562	553 Added 5.81%	10,071 $945,000
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $358,077 - $537,002	-7,588 Reduced 44.36%	9,518 $645,000
Q4 2022 Jan 20, 2023	SELL	$30.35 - $53.15 $104,798 - $183,526	-3,453 Reduced 16.8%	17,106 $0
Q3 2022 Dec 02, 2022	BUY	$31.97 - $49.37 $103,550 - $159,909	3,239 Added 18.7%	20,559 $668,000
Q2 2022 Jul 20, 2022	BUY	$35.61 - $76.23 $306,388 - $655,882	8,604 Added 98.72%	17,320 $682,000
Q1 2022 May 03, 2022	BUY	$57.56 - $82.54 $150,576 - $215,924	2,616 Added 42.89%	8,716 $609,000
Q4 2021 Mar 10, 2022	BUY	$72.5 - $100.68 $442,250 - $614,148	6,100 New	6,100 $475,000
Q3 2021 Nov 15, 2022	SELL	$90.24 - $124.05 $292,919 - $402,666	-3,246 Reduced 18.74%	14,074 $1.34 Million
Q2 2021 Nov 15, 2022	BUY	$93.66 - $139.27 $62,283 - $92,614	665 Added 7.72%	9,279 $1.15 Million
Q1 2021 Nov 15, 2022	SELL	$116.57 - $155.01 $1.01 Million - $1.35 Million	-8,706 Reduced 50.27%	8,614 $1.14 Million
Q4 2020 Nov 15, 2022	SELL	$99.61 - $142.12 $108,475 - $154,768	-1,089 Reduced 11.58%	8,316 $1.1 Million
Q3 2020 Nov 15, 2022	SELL	$72.92 - $102.01 $1,385 - $1,938	-19 Reduced 0.2%	9,405 $959,000
Q2 2020 Nov 15, 2022	BUY	$55.75 - $92.75 $315,935 - $525,614	5,667 Added 150.84%	9,424 $819,000
Q4 2019 Nov 15, 2022	SELL	$77.66 - $99.74 $1.05 Million - $1.35 Million	-13,563 Reduced 78.31%	3,757 $347,000

Others Institutions Holding EXAS

# of Institutions

670

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Account

Values First Advisors, Inc. Exact Sciences Corp Transaction History